Latest News about CRSP
Recent news which mentions CRSP
Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday
Today 10:03 EDT
From Benzinga
3 Monster Stocks to Hold for the Next 10 Years
July 17, 2025
From Motley Fool
CRISPR Stock Surges in Recent Weeks: What's Going On?
July 10, 2025
From Benzinga
10 Monster Stocks to Hold for the Next 10 Years
July 08, 2025
From Motley Fool
From Benzinga
2 Beaten-Down Stocks With Massive Upside Potential
July 03, 2025
From Motley Fool
2 Growth Stocks to Buy Hand Over Fist in July
July 02, 2025
From Motley Fool
44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy
June 27, 2025
From Benzinga
The Best Stocks to Invest $1,000 in Right Now
June 24, 2025
From Motley Fool
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
June 21, 2025
From Motley Fool
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
June 20, 2025
From Benzinga
From Benzinga
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
June 17, 2025
From Benzinga
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
June 09, 2025
From Benzinga
The Best Stocks to Invest $1,000 in Right Now
June 03, 2025
From Motley Fool
From Motley Fool
5 Monster Stocks to Hold for the Next 10 Years
May 20, 2025
From Motley Fool
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
May 20, 2025
From Motley Fool
Tickers
CRSP
From Motley Fool
From TalkMarkets
Tickers
CRSP
From Motley Fool
2 Biotech Stocks That Are Screaming Buys in May
May 13, 2025
From Motley Fool
Tickers
CRSP
From Motley Fool
3 Monster Stocks to Hold for the Next 10 Years
May 10, 2025
From Motley Fool
From Motley Fool
CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst
May 07, 2025
From Benzinga
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
May 07, 2025
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
